A Leadership Transition, and a Real Margin-Expansion Quarter
This filing covers the quarter ended December 31, 2025 - Q3 of Avenue Supermarts' FY2026, the festive/Diwali quarter. Revenue grew 13.33% year-on-year to Rs. 18,100.88 crore, and net income grew 18.28% to Rs. 855.78 crore, on Operating Income (reconstructed) growth of 19.62% to Rs. 1,212.01 crore - genuine margin expansion, with operating income growing meaningfully faster than revenue, and the best operating-income growth rate since Q4 FY2024.
Employee Benefit Expense stands out even against that otherwise-strong quarter, up 30.48% year-on-year to Rs. 397.75 crore - the second-highest employee-cost growth rate anywhere in this site's coverage of DMart, just behind 32.11% one quarter earlier, and still well ahead of revenue growth. The same board meeting that approved this quarter's results also disclosed that Managing Director & CEO Ignatius Navil Noronha's current term would conclude on January 31, 2026, with Anshul Asawa (then CEO Designate) appointed as his successor from April 1, 2026, alongside four other senior-management role changes effective February 1, 2026. This site's coverage cannot confirm from the documents available that the employee-cost jump is directly tied to this leadership transition (a severance provision, a retention package, or a compensation restructuring tied to the incoming team would all be plausible mechanisms, but none is itemized in this bare filing), and it should be read as a notable coincidence worth watching rather than a confirmed causal link - the next quarter's filing, covering the actual handover period, is the one that would confirm or rule this out.
Finance Costs grew 102.20% year-on-year to Rs. 36.82 crore - still more than doubling, but actually a deceleration from Q2 FY2026's 114.22%, breaking a three-quarter streak of accelerating growth (41% → 84% → 114%). The filing's own footnotes already disclose the source: a commercial-paper program in three tranches - Rs. 100 crore and Rs. 200 crore at 6.00% p.a. (both matured by quarter-end) and a further Rs. 200 crore at 6.10% p.a. issued December 26, 2025 and outstanding at quarter-end - even though no full balance sheet is disclosed as a separable quarter figure in this filing type.
The Prescription
Two things happened in the same quarter that the company has not connected in its own disclosures: the second-largest employee-cost jump in this site's multi-year coverage, and a CEO succession announcement. Whether or not they're related, disclosing them separately without any cross-reference leaves a reader to notice the coincidence manually rather than being told directly whether one-off transition costs are embedded in this quarter's payroll line. On the finance-cost trend: three straight quarters of acceleration breaking into a deceleration this quarter is worth watching rather than treating as settled either way, and the absence of a full balance sheet across this entire filing type - even though the commercial-paper program itself is disclosed in a footnote - remains the single biggest limitation on being able to properly assess DMart's overall borrowing picture.
Key Financial Metrics
Quarter and nine months ended December 31, 2025 (consolidated), compared against Q3 FY2025 (quarter ended December 31, 2024)
FX: INR 89.77 = USD 1 (December 31, 2025 close).
Festive-season seasonality note: this quarter contains Diwali and the bulk of India's autumn/winter festive retail spending, structurally the strongest quarter of DMart's fiscal year.
| Metric | Q3 FY2026 (INR) | Q3 FY2026 (USD) | YoY Change | Note |
|---|---|---|---|---|
| Net Revenue (revenue from operations) | Rs. 18,100.88 crore | ~$2,016.4M | ✅ +13.33% | |
| Total Income (incl. other income) | Rs. 18,117.81 crore | ~$2,018.2M | ✅ +13.26% | Other income fell YoY |
| Total Expenses | Rs. 16,942.62 crore | ~$1,887.3M | ✅ +12.94% | Slower than revenue - genuine margin expansion |
| Operating Income (EBIT, reconstructed) | Rs. 1,212.01 crore | ~$135.0M | ✅ +19.62% | 6.70% margin, up from 6.34% a year ago |
| Adjusted EBITDA» (reconstructed) | Rs. 1,480.30 crore | ~$164.9M | ✅ +19.25% | 8.18% margin, up from 7.77% |
| Finance Costs | Rs. 36.82 crore | ~$4.1M | 🔴 +102.20% | Decelerating from Q2's 114.22%, breaking a three-quarter acceleration streak (41% → 84% → 114%) |
| Profit Before Tax | Rs. 1,175.19 crore | ~$130.9M | ✅ +18.10% | |
| Tax Expense | Rs. 319.41 crore | ~$35.6M | ⚠️ +17.64% | Effective rate 27.18%, down slightly from 27.28% a year ago |
| Net Income | Rs. 855.78 crore | ~$95.3M | ✅ +18.28% | 4.73% net margin, up slightly from 4.53% |
| Basic / Diluted EPS | ~Rs. 13.15 / ~Rs. 13.08 (derived: Rs. 855.78 crore ÷ 65.073 crore shares) | ~$0.146 / ~$0.146 | ✅ ~+18.3% | EPS not separately disclosed as a distinct figure in this filing; derived from net income and shares outstanding |
Operating Income and Adjusted EBITDA are reconstructed as PBT + Finance Costs [+ D&A for EBITDA]. No balance sheet or cash flow statement is disclosed as a separable quarter figure in this filing type. Paid-up equity share capital held flat at Rs. 650.73 crore (~65.07 crore shares).
Beyond the Usual
A CEO Succession, Disclosed the Same Day as a Near-Record Employee-Cost Jump
The Board of Directors, at the meeting held January 10, 2026 that approved this quarter's results, also took on record the conclusion of Ignatius Navil Noronha's term as Managing Director effective the close of business on January 31, 2026, and approved Anshul Asawa's appointment as CEO from February 1, 2026 and as Managing Director for a three-year term from April 1, 2026 (subject to shareholder approval). The same board meeting designated four other officials as Senior Management Personnel effective February 1, 2026, due to a change in reporting structure. This is a meaningful bench of leadership change disclosed in a single meeting, and it lands in the same quarter as this arc's second-largest employee-cost jump (+30.48%, just behind Q2 FY2026's +32.11%) - worth flagging as a coincidence this site's available documents cannot confirm or rule out as related.
Finance Costs, Three Quarters of Acceleration, Then a Break
41.28% ([Q4 FY2025](/analysis/dmart/2025-03/)), 83.58% ([Q1 FY2026](/analysis/dmart/2025-06/)), 114.22% ([Q2 FY2026](/analysis/dmart/2025-09/)), 102.20% (this quarter) - three consecutive quarters of accelerating YoY finance-cost growth, broken this quarter by a deceleration. The absolute number (Rs. 36.82 crore) remains a small fraction of revenue, and this quarter's own footnotes do disclose the proximate source - a Rs. 100 crore and a Rs. 200 crore commercial-paper tranche at 6.00% p.a. (both matured by quarter-end) plus a further Rs. 200 crore tranche at 6.10% p.a. outstanding at quarter-end - but the absence of a full balance sheet anywhere in this filing type to show total borrowings and leverage remains the clearest structural gap in this site's DMart coverage.
Stock Price and Valuation
DMart's stock closed this quarter at Rs. 3,782.20, down 15.48% from Q2 FY2026's Rs. 4,475.40 close - a sharp festive-quarter pullback despite genuinely improving operating-income growth this quarter, suggesting the market reacted more to the leadership transition and the finance-cost trend than to the underlying P&L.
DMart traded at roughly Rs. 2,46,119 crore (~$27.4B) market capitalization at this quarter's close (December 31, 2025) - a trailing-twelve-month P/E near 86x, down from Q2 FY2026's ~104x as the price fell faster than TTM earnings, which continued growing.
| Item | Value |
|---|---|
| Share price (December 31, 2025 close) | Rs. 3,782.20 |
| Shares outstanding | ~65.07 crore |
| Market capitalization | ~Rs. 2,46,119 crore (~$27.4B) |
| Enterprise value | Not computable without a balance sheet - market cap used as a proxy below |
No real DCF is possible without a balance sheet. Trailing-twelve-month net income through this quarter - Rs. 855.78 crore (this quarter) plus Q2 FY2026 (Rs. 684.85 crore), Q1 FY2026 (Rs. 772.81 crore), and Q4 FY2025 (Rs. 550.79 crore) - totals Rs. 2,864.23 crore, implying a trailing P/E near 85.9x, the cheapest multiple since Q3 FY2025. Between the CEO transition and a finance-cost line still more than doubling year-on-year, this looks like a market pricing in genuine near-term uncertainty rather than a valuation call on the P&L alone - the next quarter, the incoming CEO's first full one, is the one to watch for whether either thread resolves or compounds further.
Peer-multiple comparison (trailing-twelve-month basis):
| Metric | This Quarter (TTM through Q3 FY2026) | Prior Quarter (TTM through Q2 FY2026) |
|---|---|---|
| TTM Net Income | Rs. 2,864.23 crore | Rs. 2,793.10 crore |
| Market Capitalization | ~Rs. 2,46,119 crore (~$27.4B) | ~Rs. 2,91,228 crore (~$32.8B) |
| Trailing P/E | ~85.9x | ~104.3x |
TTM earnings actually grew this quarter while the multiple compressed sharply - the price fell faster than trailing earnings did, consistent with the market discounting the CEO-transition and finance-cost uncertainty rather than the P&L itself.
Bull/base/bear scenario check (multiple-based sanity check applied to TTM earnings, not a full multi-year DCF - this site's established range across the arc, since a balance sheet-based EV/EBITDA build isn't available for this filing type):
| Scenario | Key assumption | Implied trailing P/E | Implied price/share |
|---|---|---|---|
| Bear | Multiple reverts toward the low end of this arc's observed trading range | 70x | ~Rs. 3,081 |
| Base | Multiple settles near the middle of this arc's observed trailing-P/E band | 100x | ~Rs. 4,402 |
| Bull | Multiple recovers toward the richest level this arc has shown | 130x | ~Rs. 5,722 |
| Current (period-end close) | — | ~85.9x (actual) | Rs. 3,782.20 |
The actual close sits between the bear and base scenarios, closer to the base case - the cheapest positioning in over a year of this site's coverage, and one that already reflects real uncertainty rather than assuming it away.